サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1392697

ヘパリンの世界市場レポート 2024年

Heparin Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
ヘパリンの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

ヘパリン市場規模は近年力強く成長しています。2023年の92億9,000万米ドルから2024年には98億6,000万米ドルに、CAGR6.2％で拡大します。実績期間の成長は、心血管疾患の有病率の増加、抗凝固療法を必要とする外科手術の進歩、高齢化人口の増加、深部静脈血栓症患者の増加、腎透析における用途の拡大に起因しています。

外科手術の増加は、今後ヘパリン市場の成長を押し上げると予想されます。外科的処置とは、身体の組織や臓器にアクセスし、操作するために切開したり、低侵襲技術を用いたりする医療介入や治療方法を指します。外科手術の増加に伴い、手術中や手術後の血栓を防ぐために抗凝固剤であるヘパリンの使用が必要となるため、ヘパリンの需要が高まり、ヘパリン市場の成長が促進されます。例えば、2022年4月、米国を拠点とする認定形成外科医の組織であるAesthetic Societyが発表した報告書によると、外科手術は54%増加し、2021年には平均320件の外科手術が形成外科医によって行われました。一般的な外科手術の費用も、2021年には平均6％上昇しました。したがって、外科手術の増加がヘパリン市場の成長を牽引しています。

2023年のヘパリン市場で最大の地域は北米です。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。

目次

第1章 エグゼクティブサマリー

第2章 ヘパリン市場の特徴

第3章 ヘパリン市場の動向と戦略

第4章 ヘパリン市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界のヘパリン市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年から2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 ヘパリン市場セグメンテーション

  • 世界のヘパリン市場、製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 未分画ヘパリン
  • 低分子量ヘパリン（LMWH）
  • 超低分子量ヘパリン（ULMWH）
  • 世界のヘパリン市場、由来別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • ウシ
  • ブタ
  • 世界のヘパリン市場、投与経路別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 静脈内
  • 皮下
  • 世界のヘパリン市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 静脈血栓塞栓症
  • 心房細動
  • 腎障害
  • 冠動脈疾患
  • その他の用途
  • 世界のヘパリン市場、流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 病院薬局
  • ドラッグストアおよび小売薬局
  • オンライン薬局

第7章 ヘパリン市場の地域および国分析

  • 世界のヘパリン市場、地域別、実績および予測、2018-2023、2023-2028F、2033F
  • 世界のヘパリン市場、国別、実績および予測、2018-2023、2023-2028F、2033F

第8章 アジア太平洋のヘパリン市場

  • 概要
  • 地域情報、COVID-19症の影響、市場情報、背景情報、政府の取り組み、規制、規制機関、主要団体、課税額、法人税構造、投資、主要企業
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 投与経路別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第9章 中国のヘパリン市場

第10章 インドのヘパリン市場

第11章 日本のヘパリン市場

第12章 オーストラリアのヘパリン市場

第13章 インドネシアのヘパリン市場

第14章 韓国のヘパリン市場

第15章 西欧のヘパリン市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 投与経路別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第16章 英国のヘパリン市場

第17章 ドイツのヘパリン市場

第18章 フランスのヘパリン市場

第19章 イタリアのヘパリン市場

第20章 スペインのヘパリン市場

第21章 東欧のヘパリン市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 投与経路別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第22章 ロシアのヘパリン市場

第23章 北米のヘパリン市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 投与経路別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第24章 米国のヘパリン市場

第25章 カナダのヘパリン市場

第26章 南米のヘパリン市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 投与経路別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第27章 ブラジルのヘパリン市場

第28章 中東のヘパリン市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 投与経路別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第29章 アフリカのヘパリン市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 投与経路別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第30章 ヘパリン市場の競合情勢と企業プロファイル

  • ヘパリン市場の競合情勢
  • ヘパリン市場の企業プロファイル
    • Baxter International Inc.
    • B. Braun Medical Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Fresenius SE & Co. KGaA
    • Leo Pharma A/S

第31章 世界のヘパリン市場の競合ベンチマーキング

第32章 世界のヘパリン市場競争ダッシュボード

第33章 ヘパリン市場における主要な合併と買収

第34章 ヘパリン市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r10385

“Heparin Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on heparin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for heparin? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The heparin market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Unfractionated Heparin; Low Molecular Weight Heparin (LMWH); Ultra-Low Molecular Weight Heparin (ULMWH)
  • 2) By Source: Bovine; Porcine
  • 3) By Route of Administration: Intravenous; Subcutaneous
  • 4) By Application: Venous Thromboembolism; Atrial Fibrillation; Renal Impairment; Coronary Artery Disease; Other Applications
  • 5) By Distribution Channel: Hospital Pharmacies; Drug Stores & Retail Pharmacies; Online Pharmacies
  • Companies Mentioned: Baxter International Inc.; B. Braun Medical Inc.; Dr. Reddy's Laboratories Ltd.; Fresenius SE & Co. KGaA; Leo Pharma A/S
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Heparin refers to an anticoagulant type substance that slows the development of blood clots. Heparin is produced by the liver, lungs, and other human tissues, but it can also be produced in a lab. In order to prevent or dissolve blood clots, heparin may be injected into muscle or blood. Heparin is widely used in hospitals to prevent excessive coagulation during cardiac surgery, extracorporeal circulation, or dialysis.

The main types of heparin include unfractionated heparin, low molecular weight heparin (LMWH), and ultra-low molecular weight heparin (ULMWH). The unfractionated heparin (UFH) market refers to a class of fast-acting anticoagulant medication that prevents clot formation by combining with antithrombin. Unfractionated heparin binds to antithrombin and improves its ability to inhibit two of the body's most powerful clotting factors, factor Xa and factor IIa, in minutes. They are sourced from bovine or porcine and administered intravenous or subconscious. they are used in the treatment of venous thromboembolism, atrial fibrillation, renal impairment, coronary artery disease, and others. They are distributed through hospital pharmacies, drug stores or retail pharmacies, and online pharmacies.

The heparin market research report is one of a series of new reports from The Business Research Company that provides heparin market statistics, including heparin industry global market size, regional shares, competitors with a heparin market share, detailed heparin market segments, market trends and opportunities, and any further data you may need to thrive in the heparin industry. This heparin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The heparin market size has grown strongly in recent years. It will grow from $9. 29 billion in 2023 to $9. 86 billion in 2024 at a compound annual growth rate (CAGR) of 6. 2%. The growth in the historic period can be attributed to increased prevalence of cardiovascular diseases, advances in surgical procedures requiring anticoagulation, growth in the aging population, rise in deep vein thrombosis cases, expansion of applications in renal dialysis.

The heparin market size is expected to see strong growth in the next few years. It will grow to $12. 92 billion in 2028 at a compound annual growth rate (CAGR) of 7. 0%. The growth in the forecast period can be attributed to growing demand for low-molecular-weight heparin, expansion of heparin use in the treatment of cancer, increasing incidence of venous thromboembolism, development of biosynthetic heparin, increase in the number of emerging markets. Major trends in the forecast period include technological advancements in heparin production, emphasis on the production of safer and more bioavailable heparin, integration of digital technologies in heparin administration, adoption of biosimilars, exploration of heparin alternatives and substitutes.

The increasing prevalence of chronic diseases is significantly driving the growth of the heparin market. Chronic diseases refer to medical conditions, which last more than one year and require constant medical attention or hospitalization for specialized treatment. The changing lifestyle, eating habits, and inappropriate maintenance of body weight are the reasons for chronic conditions and a few more prolonged chronic infections lead to cancerous risk. Growing exposure to the disease has increased the demand for heparin, as they are widely used to make the blood thin during surgeries and various medical treatments. For instance, in July 2021, according to the International Diabetes Federation (IDF), a Belgium-based diabetes organization, the number of persons with diabetes worldwide is predicted to reach 537 million in 2021, 643 million in 2030, and 783 million in 2045. In addition, it was anticipated that 541 million people would have impaired glucose tolerance by 2021. Additionally, it is anticipated that in 2021, nearly 6. 7 million people between the ages of 20 and 79 will pass away due to complications from diabetes. Therefore, the increasing prevalence of chronic diseases will drive the growth of the heparin market.

The rising surgical procedure is expected to boost the growth of the heparin market going forward. A surgical procedure refers to a medical intervention or treatment method that involves making incisions or using minimally invasive techniques to access and manipulate the body's tissues or organs. The growing number of surgical procedures necessitates the use of heparin, an anticoagulant, to prevent blood clots during and after surgery, thereby fueling the demand for heparin and driving the growth of the heparin market. For instance, in April 2022, according to a report published by the Aesthetic Society, a US-based organization of board-certified plastic surgeons, surgical procedures saw a 54% increase, with an average of 320 surgical procedures performed by plastic surgeons in 2021. The cost of a typical surgical procedure also rose by 6% on average in 2021. Therefore, the rising surgical procedure is driving the growth of the heparin market.

Product advancement is a key trend gaining popularity in the heparin market. Key players and their research wings are increasingly focusing on developing an advanced and improved heparin or heparin prefilled syringe with precision and convenience to increase their business reach and presence across the globe. For instance, in April 2021, Fresenius Kabi USA, a US-based healthcare company, launched Freeflex IV bags. These are low-concentration sodium heparin in ready-to-use sodium chloride injection. These bags consist of 1,000 USP units of sodium heparin in a 500 mL infusion bag with 0. 9% sodium chloride and 2,000 USP units of sodium heparin in a 1,000 mL infusion bag with 0. 9% sodium chloride. simple, These heparin bags help reduce medication errors and guarantee patient safety.

Major companies operating in the heparin market are adopting strategic partnerships approach to provide the manufacturing efficiency of bioengineered heparin to individuals, businesses, and governments. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in January 2022, Optimvia, a US-based biopharmaceutical company, partnered with Ginkgo Bioworks, a US-based biotech company. Optimvia officials aim to utilize Ginkgo's cell and enzyme engineering platform to enhance their biosynthetic heparin manufacturing technology. Additionally, they seek to leverage Ginkgo's expertise in fermentation process development to expedite the performance improvements of their heparin production.

In May 2022, Fresenius Kabi, a Germany-based healthcare company, acquired Ivenix Inc. for an undisclosed amount. The integration of Ivenix's top-notch hardware and software solutions with Fresenius Kabi's intravenous fluids and infusion devices will establish an extensive and leading portfolio of high-quality products. This lays a robust and fast-paced foundation to foster sustainable expansion within the high-value MedTech sector. Ivenix Inc. is a US-based medical technology company.

Major companies operating in the in the heparin market report are Baxter International Inc., B. Braun Medical Inc., Dr. Reddy's Laboratories Ltd., Fresenius SE & Co. KGaA, Leo Pharma A/S, Aspen Pharmacare plc, Bioiberica SA, Biomedical Foscama Group, Biovet SA, Changzhou Qianhong Bio-pharma Co. Ltd., CSPC NBP Pharmaceutical Co. Ltd., Gelita Medical AG, Intas Pharmaceuticals Ltd., Nanjing King-friend Biochemical Pharmaceutical Co. Ltd., Opocrin Pharmaceuticals Ltd., Pfizer Inc., Pharma Action Ltd., Rovi Pharma Industrial Services Ltd., Sagent Pharmaceuticals Inc., Sanofi S. A., Shenzhen Hepalink Pharmaceutical Co. Ltd., Sichuan Deebio Pharmaceutical Co. Ltd., Teva Pharmaceuticals Industries Ltd., VAV Life Sciences Inc., Viatris Inc., Wanbang Biopharmaceuticals Co. Ltd., Wockhardt Ltd., Xinbai Pharmaceuticals Co. Ltd., Yino Pharma Co. Ltd., TEGA Therapeutics Inc.

North America was the largest region in the heparin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heparin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the heparin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The heparin market consists of sales of enoxaparin, dalteparin, and nadroparin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Heparin Market Characteristics

3. Heparin Market Trends And Strategies

4. Heparin Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Heparin Market Size and Growth

  • 5.1. Global Heparin Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Heparin Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Heparin Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Heparin Market Segmentation

  • 6.1. Global Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Unfractionated Heparin
  • Low Molecular Weight Heparin (LMWH)
  • Ultra-Low Molecular Weight Heparin (ULMWH)
  • 6.2. Global Heparin Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bovine
  • Porcine
  • 6.3. Global Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Intravenous
  • Subcutaneous
  • 6. 4. Global Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Venous Thromboembolism
  • Atrial Fibrillation
  • Renal Impairment
  • Coronary Artery Disease
  • Other Applications
  • 6. 5. Global Heparin Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies

7. Heparin Market Regional And Country Analysis

  • 7.1. Global Heparin Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Heparin Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Heparin Market

  • 8.1. Asia-Pacific Heparin Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8. 4. Asia-Pacific Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Heparin Market

  • 9.1. China Heparin Market Overview
  • 9.2. China Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9. 4. China Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Heparin Market

  • 10.1. India Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Heparin Market

  • 11.1. Japan Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Heparin Market

  • 12.1. Australia Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Heparin Market

  • 13.1. Indonesia Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Heparin Market

  • 14.1. South Korea Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Heparin Market

  • 15.1. Western Europe Heparin Market Overview
  • 15.2. Western Europe Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15. 4. Western Europe Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Heparin Market

  • 16.1. UK Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Heparin Market

  • 17.1. Germany Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Heparin Market

  • 18. 5. France Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 6. France Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 7. France Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Heparin Market

  • 19. 9. Italy Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Heparin Market

  • 20.13. Spain Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Heparin Market

  • 21.1. Eastern Europe Heparin Market Overview
  • 21.2. Eastern Europe Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21. 4. Eastern Europe Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Heparin Market

  • 22.1. Russia Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Heparin Market

  • 23.1. North America Heparin Market Overview
  • 23.2. North America Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23. 4. North America Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Heparin Market

  • 24.1. USA Heparin Market Overview
  • 24.2. USA Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24. 4. USA Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Heparin Market

  • 25.1. Canada Heparin Market Overview
  • 25.2. Canada Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25. 4. Canada Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Heparin Market

  • 26.1. South America Heparin Market Overview
  • 26.2. South America Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26. 4. South America Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Heparin Market

  • 27.1. Brazil Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Heparin Market

  • 28.1. Middle East Heparin Market Overview
  • 28.2. Middle East Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28. 4. Middle East Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Heparin Market

  • 29.1. Africa Heparin Market Overview
  • 29.2. Africa Heparin Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Heparin Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29. 4. Africa Heparin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Heparin Market Competitive Landscape And Company Profiles

  • 30.1. Heparin Market Competitive Landscape
  • 30.2. Heparin Market Company Profiles
    • 30.2.1. Baxter International Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1. 4. Financial Performance
    • 30.2.2. B. Braun Medical Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2. 4. Financial Performance
    • 30.2.3. Dr. Reddy's Laboratories Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3. 4. Financial Performance
    • 30.2. 4. Fresenius SE & Co. KGaA
      • 30.2. 4.1. Overview
      • 30.2. 4.2. Products and Services
      • 30.2. 4.3. Strategy
      • 30.2. 4. 4. Financial Performance
    • 30.2. 5. Leo Pharma A/S
      • 30.2. 5.1. Overview
      • 30.2. 5.2. Products and Services
      • 30.2. 5.3. Strategy
      • 30.2. 5. 4. Financial Performance

31. Global Heparin Market Competitive Benchmarking

32. Global Heparin Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Heparin Market

34. Heparin Market Future Outlook and Potential Analysis

  • 34.1 Heparin Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Heparin Market In 2028 - Segments Offering Most New Opportunities
  • 34. 3 Heparin Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35. 4. Research Inquiries
  • 35. 5. The Business Research Company
  • 35. 6. Copyright And Disclaimer